GLAXOSMITHKLINE PHARMACEUTICALS
|
The Current P/B Ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 20.20.
Share Price | ₹2,078.0 | May 06,2024 |
Market Cap | ₹35,200.5 Cr | |
Book Value | ₹1,743.0 Cr | Mar2023 - Consolidated Results |
Price/Book | 20.20x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of GLAXOSMITHKLINE PHARMACEUTICALS
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹35,200.5 Cr] as on May 06,2024
(/) Book Value [ ₹1,743.0 Cr] based on Mar2023 - Consolidated Results
(=) P/B Ratio [ 20.20x ]
Thus, for GLAXOSMITHKLINE PHARMACEUTICALS , the investors are currently willing to pay '20.20 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of GLAXOSMITHKLINE PHARMACEUTICALS !
The chart below summarizes the trend in P/B Ratio of GLAXOSMITHKLINE PHARMACEUTICALS over the last five years.
Historical PB (Price/Book ) ratio chart of GLAXOSMITHKLINE PHARMACEUTICALS
PB Ratio Performance Analysis for GLAXOSMITHKLINE PHARMACEUTICALS
- GLAXOSMITHKLINE PHARMACEUTICALS 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 12.37x.
- GLAXOSMITHKLINE PHARMACEUTICALS 's operated at median p/b ratio of 11.59x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLAXOSMITHKLINE PHARMACEUTICALS 's p/b ratio peaked in Mar2021 at 16.51x.
- GLAXOSMITHKLINE PHARMACEUTICALS 's p/b ratio hit its five-year low in Mar2019 of 10.29x.
How does GLAXOSMITHKLINE PHARMACEUTICALS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
GLAXOSMITHKLINE PHARMACEUTICALS | 1,742.95 | 20.20 | 35,200.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 55,995.40 | 6.55 | 367,026.0 |
CIPLA LTD | 23,346.00 | 4.92 | 114,925.0 |
DR REDDYS LABORATORIES LTD | 23,140.40 | 4.54 | 105,109.0 |
ZYDUS LIFESCIENCES LTD | 17,515.80 | 5.87 | 102,736.0 |
DIVIS LABORATORIES LTD | 12,767.10 | 8.23 | 105,128.0 |
MANKIND PHARMA LTD | 7,435.16 | 12.31 | 91,490.4 |
TORRENT PHARMACEUTICALS LTD | 6,198.07 | 14.83 | 91,906.5 |
LUPIN LTD | 12,315.60 | 6.22 | 76,554.6 |
AUROBINDO PHARMA LTD | 26,839.80 | 2.54 | 68,144.7 |
ABBOTT INDIA LTD | 3,146.02 | 17.40 | 54,743.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs GLAXOSMITHKLINE PHARMACEUTICALS 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.54x |
Max industry PB | 20.20x |
Median industry PB | 6.55x |
Average industry PB | 9.42x |
You may also like the below Video Courses